Skip to Highlights

A firm protested a Department of Veterans Affairs contract award for the drug clozapine, contending that the agency's evaluation of proposals was unreasonable and not consistent with the evaluation factors set forth in the solicitation. GAO found that the protester was not prejudiced by the agency's alleged defective evaluation where the record shows that, even if the protester had been aware of the manner in which the agency evaluated proposals, it would not have submitted a different proposal that would have had a reasonable possibility for award, particularly given its significantly high price. Accordingly, the protest was denied.

GAO Contacts